NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Atomik Labz? Mail in a sample (US only) and let us test it.

Test my supply
+1 more ↓
69%
Finnrick rating
#327 of 500 ranked vendors
36 of 45 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Atomik Labz shows its strongest purity-focus evidence in Retatrutide and GHK-Cu, with Tirzepatide and Semaglutide also clearing but on narrower batch records. Weakness is dispersed across BPC-157 misses and mixed CJC-1295, Ipamorelin, and PT-141 results; the record is recent, yet batch clustering and fill variability leave uncertainty.

methodology →
vendor intelligence report
Vendor Intelligence Report: Atomik Labz

Wayback footers, Florida registry negatives, and live legal-page scrubbing trace Atomik Labz from changing JE Production names to no named counterparty. The report maps Solution Peptides and Warrior Peptides links, affiliate/referral rails, payment infrastructure, and batch-specific complaints.

29 pages7 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.55
87%
4
2
Retatrutide
$5.17
86%
10
3
Tirzepatide
$13.00
81%
5
4
Semaglutide
$13.00
72%
4
5
Melanotan II
$2.90
69%
4
6
Ipamorelin
$5.80
66%
5
7
PT-141
$3.70
62%
4
8
BPC-157
$6.00
48%
4
9
CJC-1295
$6.60
36%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%5 May 2025: 43%6 May 2025: 48%6 May 2025: 52%6 May 2025: 60%6 May 2025: 62%6 May 2025: 62%6 May 2025: 62%6 May 2025: 63%6 May 2025: 63%6 May 2025: 63%6 May 2025: 63%6 May 2025: 63%6 May 2025: 63%6 May 2025: 64%6 May 2025: 63%7 May 2025: 61%7 May 2025: 61%7 May 2025: 60%7 May 2025: 61%7 May 2025: 60%7 May 2025: 60%8 May 2025: 60%8 May 2025: 60%20 May 2025: 59%20 May 2025: 59%20 May 2025: 59%20 May 2025: 59%21 May 2025: 60%21 May 2025: 60%21 May 2025: 61%21 May 2025: 61%25 Sep 2025: 62%25 Sep 2025: 62%4 Mar 2026: 64%4 Mar 2026: 65%11 May 2026: 65%12 Jun 2026: 65%3 Aug 2026: 66%12 Aug 2026: 66%27 Oct 2026: 66%17 Nov 2026: current 69%43%64%69%May 25Nov 26
Peptide testing

Ordered peptides from Atomik Labz? Mail in a sample (US only) and let us test it.

Test my supply
Atomik Labz test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
27 Oct 2026
Pass
Retatrutide
lab nameView COA
12 Aug 2026
Pass
Retatrutide
lab nameView COA
3 Aug 2026
Pass
Tirzepatide
lab nameView COA
12 Jun 2026
Pass
Retatrutide
lab nameView COA
11 May 2026
Pass
Retatrutide
lab nameView COA
4 Mar 2026
Pass
Retatrutide
lab nameView COA
4 Mar 2026
Pass
Retatrutide
lab nameView COA
25 Sep 2025
Pass
CJC-1295 (No DAC)
lab nameView COA
25 Sep 2025
Pass
Ipamorelin
lab nameView COA
21 May 2025
Pass
PT-141
lab nameView COA
1-10 of 45

About Atomik Labz test results from Finnrick

Atomik Labz is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 45 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Atomik Labz peptides in this dataset are Melanotan II (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 45 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Atomik Labz? Mail in a sample (US only) and let us test it.

Test my supply